Related Experiment Video

Updated: Jun 13, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

Histoplasmosis

Kenneth S Knox1, Chadi A Hage

  • 1University of Arizona College of Medicine and Southern Arizona VA HealthCare System, Tucson, Arizona, USA. chage@iupui.edu

Proceedings of the American Thoracic Society
|May 14, 2010
PubMed

Insights

Histoplasmosis, a common North American fungal infection, presents a wide clinical spectrum. This review emphasizes updated diagnosis and treatment for various histoplasmosis syndromes.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Histoplasmosis is the most common endemic fungal infection in North America.
  • Clinical presentation varies widely, from asymptomatic cases to severe disseminated disease.
  • Chronic forms of healed histoplasmosis can also cause significant health issues.

Purpose of the Study:

  • To provide an overview of histoplasmosis, a significant endemic mycosis.
  • To emphasize current diagnostic methods and treatment strategies.
  • To offer recommendations for managing different clinical syndromes of histoplasmosis.

Main Methods:

  • Review of current literature on histoplasmosis.
  • Analysis of diagnostic tools and treatment options.
  • Synthesis of clinical presentation factors including infectious load, immune status, and lung function.

Main Results:

  • Clinical manifestations are influenced by infectious dose, host immunity, and pulmonary status.
  • Diagnostic approaches and therapeutic interventions are tailored to the specific clinical scenario and disease severity.
  • Recent advancements in diagnostic and therapeutic options are now accessible.

Conclusions:

  • Histoplasmosis diagnosis and management require a nuanced approach based on clinical presentation.
  • Updated diagnostic tools and treatments offer improved patient outcomes.
  • This overview provides essential guidance for clinicians managing histoplasmosis.

More Related Videos

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions09:56

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions

Published on: August 12, 2010

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

Related Concept Videos

Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...